Strikingly, PRPS2 is specifically upregulated to enhance nucleotide and protein biosynthesis in cancer cells with oncogene c-Myc overexpression, and the knockout of PRPS2 is synthetically lethal to such cancer cells30–34. This evidence concerns the gene MYC and cancer.